Short ZIOP. Undisclosed FDA warning letter
October 21, 2012
A close investigation of Ziopharm (ZIOP) reveals an undisclosed FDA warning letter and instability with Palifosfamide
A close investigation of Ziopharm (ZIOP) reveals an undisclosed FDA warning letter and instability with Palifosfamide
Variable Interest Entity (“VIE”) structures were first introduced by Chinese companies listing in the US as far back as the year 2000 when SINA had its initial public offering on the NASDAQ. Effectively the VIE structure means that equity holders have a somewhat indirect financial interest in the revenue and earnings stream and do not…